Summarv a-thal-2 determinant. which is associated with a mild a chain Seventy children homozygous for H h S (SS) and their 111 heterozygous (AS) parents were evaluated through their erythrocytic indices. hernoglohin composition, and occasionally through in vitro l i b chain synthesis values.
Three groups o f SS patients and of AS parents were identified hased on differences in degree of microcytosis (MCV) and (degree of hypochromia ( M C H ) values. The level of H h S i n the H h S heterozygotes showed a trimodal distribution. Five SS patients had an a-thalassemia homozygosity (aoa/aua; pS/ps) which was characterized hy a distinct microcytosis and hypochromia (MCV, 5 70 fl: MCt1, 3 2 2 pa). Nine SS patients had an a-thalassemia heterozygosity (aU/a/aa; ps/Ps) with an M C V value of 71 to 78 fl, and an M C H value o f 21.3 to 26.5 pg. Four AS parents had an a-thalassemia-2 homozygosity with values o f M C V 71 fl and M C f 1 5 23.5 . The level of H h S was <31%. Thirty-nine AS parents had an a-thalassemia-2 heterozygosity characterized hy an M C V value o f 72 to 79 fl, an M C H value o f 23.6 to 26.5 , and a level of Hh S ranging hetween 31.0 and 36.8%.
The H h Ap level i n SS patients was significantly correlated with the RBC counts and the M C V and M C H (r = 0.38, -0.52, and -0.47. respectively). Significant correlations in AS parents were also noted hetween the MCV, MCH, RBC, and H h S percentages ( r = 0.62, 0.68, and -0.49, respectively) .
Although the data are limited, the simultaneous occurrence o f an a-thal-2 homozygosity seems to decrease the level of H b F i n sickle cell anemia. The presence o f an a-thal-2 heterozygosity or homozygosity together with an SS or AS condition resulted in identifiable hematologic phenotypes.
Speculation
The occurrence of microcytosis and hypochromia among SS patients i n association with increased erythrocyte counts and H h A2 percentages indicates the concomitant presence of a-thalassemia-provided / 3 chain deficiencies have been excluded through hiosynthetic experiments or through family studies. The a-thal-2 heterozygosity (a0a/aa; Ps/P'), which is associated with a mild a chain deficiency, results in a slight decrease of the degree o f microcytosis and hypochromia values. O n the other hand, the athal-2 homozygosity (aUa/a"a; PS/PS) and perhaps also the athal-l heterozygosity (aoa"/aa; fiS/PS), which are associated with of the four a chain genes. is
The AS condition and or homozygosity (cr"n/ conditions can be idenproportions of Hb S. the degree of microcytosis and hypochromia values. and the a/non-a synthesis ratio, all of which are decreased when compared with similar data in Htj S heterozygotes who lack a-thalassemia ( a a l a a ; P/ RS).
These o sewations offer an additional approach for the diagnosis and valuation of the a-thalassemia conditions occurring among H b S homozygotes. The present study documents the occurrence of these two types of a-thalassemia in an unselected group of 1 S children who attend the Pediatric Clinic of the Comprehedsive Sickle Cell Center in Augusta. GA. The prevalence of a-thal-2 in this group indicated by hematologic abnormalities w& found to be higher than previously predicted. Correlation anhlyses of several hematological parameters provided details regahding the effect of the a-thal-2 gene on these parameters.
I MATERIALS A N D METHODS

I
PATlENTS children who attend the Pediatric Sickle Cell Clinic participated in this study. Their ages varied from 3 to 13.5 36 were females, and 34 were males. Blood samples were collec/ed by venipuncture with EDTA as anticoagulant. The clinical and hematologic heterogeneity of sickle cell anemia (SS) and Hb S heterozygosity (AS) has been the subject of various studies (2, 5-9, 14. 16. 17) . These studies have indicated that the 36.89 (presumed diagnosis: dla/ua: pA/fl') Table I. Table 2 summarizes -U similar data for 1 I I AS parents. The correlations between some of ,% the data are summarized in Table 3 .
Among the SS patients, the hematologic values were about the c;. (Tables I and 3 excludes a P-thalassemia condition. All five patients in group 3 had a much lower level of H b F when compared to the SS patients in groups 1 and 2 (Table I) . Splenomegaly was noted in all five cases forming group 3. Sixty-eight of the 1 1 I H b S heterozygotes had no a-thalassemia heterozygotes for a-thal-2 ( Table 2 ). The father of one SS child in group 3 had a very low MCV, MCH, and percent Hb S and is 
"umbers between brackets identify the groups of patients with values that differ fro11 the listed value at a P value of less than 0.05. included i' parents group 3 with the a0a/a"a; PA//?' or aOa"/aa;
PA/P con 4 itions. However, examination of both paternal grandparents shdwed segregation of an a-thal-2 like condition excluding the presende of the a-thal-l gene in this family (these data will be published plsewhere). Thirty-one of I I I parents had a-thal-2 heterozygo&ity ( 0.4 (S.D.) ; n = 51 probably results from a moderate a chain deficiency. In a previous study involCing many H b S heterozygotes, a correlation between the assume! number of active a chain genes and the H b A:! values was also obtained (8. 14) . It is much more difficult to decide if an a-thal-2 he~erozygosity is present. and a considerable overlap between thd groups with three or four active a chain genes makes such a distknction in individual cases often impossible. These conclusions are similar to those reached previously in a smaller survey (6) .
These o d servations imply that an elevated level of H b A2
together wiih microcytosis in patients with sickle cell syndromes need not alltomatically identify the S-/?-thal condition except when data from a family study and/or in virro Hb chain synthesis analyses suggest such a diagnosis. Although it was suggested that an a chain deficiency could promote the formation of Hb F over H b S and C in H b S or H b C homozygotes (15) (16) (17) . a recent physiochemical determination has shown that $ chains have a higher affinity than y chains for a limited supply of a chains ( I 1). Indeed. despite great variation in the Hb F level, the five a-thal-2 homozygotes had some of the lowest H b F percentages in this cohort. It stiould be noted that in a pediatric setting the H b F levels ought to be evaluated together with the age of the patient (13): howev 1 r, this age factor does not play a significant role in comparing t e levels of H b F in our patients (Table I) .
The num , ! ers of a-thal-2 heterozygotes (aUa/aa) among the 70 SS patients Qnd among I I I Hb S heterozygotes suggest a rather high a-thal-b frequency (28%) in this population. This value is I closer to that reported by Dozy et al. (4) obtained with gene mapping techniques than the figures obtained from cord blood studies (see. for instance. Ref. 8) .
The presence of a palpable spleen in all five SS-cu-thal-2 homozygotes is of special interest. and it appears that splenomegaly is another fealure of the sickle cell anemia a-thal-2 homozygosity combination. This clinical finding can lead to misdiagnosis of the condition because this feature together with a high level of Hb A? and low indices are common observations in H b S-/3"-thalassemia. Thus. family studies are critical for a differential diagnosis in these cases.
The high incidence of a-thalassemia-2 in Blacks should be kept in mind by physicians and a diagnosis of iron-deficiency anemia should not be based on low red cell indices only.
In a recent study, Powars et al. (12) indicated the absence of any correlation between hematological parameters and clinical severity of the disease. Although clinical evaluations of the patients are not included in this study. our personal observation of the SS patients indicates no evidence of differences in severity of the disease among various groups ( 18. 19).
